HVTN 142

STUDY BASICS

Are you 18 to 55 years old and in good health? You may be eligible to participate in a research study to test an experimental vaccine against HIV. This study wants to see if the study vaccine is safe and how a person’s immune system responds to it. Compensation is provided.

STUDY PURPOSE

The purpose of this study is to see if the study vaccine is safe and how a person’s immune system responds to it.  

This study hopes to answer several main questions:

• Is the study vaccine safe to give to people?
• Are people able to take the study vaccine without becoming too uncomfortable?
• How do people’s immune systems respond to the study vaccine? (Your immune system protects you from infections and diseases.)
• Does the virus used to make the study vaccine show up in people’s body fluids?

This study is testing an experimental HIV vaccine. The study vaccine is called VIR-1388. 

COULD THIS STUDY BE RIGHT FOR YOU?

• Age 18-55
• In overall good health

WHAT PARTICIPANTS CAN EXPECT

• 16-20 scheduled visits over approximately 12 months. 
• Participants may be asked to come back for clinic visits for long term follow-up at 2 years and 3 years after their injection. Long term follow-up is optional.